Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial

Background Despite their marginal benefit, about 60% of acute lower respiratory tract infections (ALRTIs) are currently treated with antibiotics in Catalonia. This study aims to evaluate the effectiveness and efficiency of a continuous disease-focused intervention (C-reactive protein [CRP]) and an i...

Descripción completa

Detalles Bibliográficos
Autores: Ruiz, Rafa, Moragas, Ana, Trapero-Bertran, Marta, Sisó, Antoni, Berenguera, Anna, Oliva, Glòria, Borràs Santos, Alícia, García Sangenís, Ana, Puig i Junoy, Jaume, Cots, Josep M., Morros, Rosa, Mora, Toni, Lanau Roig, Anna, Monfà, Ramon, Troncoso, Amelia, Abellana, Rosa M., Gálvez, Pau, Medina Perucha, Laura, Bjerrum, Lars, Amo, Isabel, Barragán, Nieves, Llor, Carl
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/44669
Acceso en línea:http://hdl.handle.net/10230/44669
http://dx.doi.org/10.1186/s13063-019-3727-3
Access Level:acceso abierto
Palabra clave:Cost-effectiveness
Cost-utility
Effectiveness
Anti-bacterial agents
Prescribing
Acute cough
Respiratory tract infections
Antimicrobial stewardship
Qualitative research
Incremental cost-utility ratio
Primary healthcare
id ES_2a4e0acdadd5e9b11de2e8d4f15508f0
oai_identifier_str oai:repositori.upf.edu:10230/44669
network_acronym_str ES
network_name_str España
repository_id_str
spelling Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trialRuiz, RafaMoragas, AnaTrapero-Bertran, MartaSisó, AntoniBerenguera, AnnaOliva, GlòriaBorràs Santos, AlíciaGarcía Sangenís, AnaPuig i Junoy, JaumeCots, Josep M.Morros, RosaMora, ToniLanau Roig, AnnaMonfà, RamonTroncoso, AmeliaAbellana, Rosa M.Gálvez, PauMedina Perucha, LauraBjerrum, LarsAmo, IsabelBarragán, NievesLlor, CarlCost-effectivenessCost-utilityEffectivenessAnti-bacterial agentsPrescribingAcute coughRespiratory tract infectionsAntimicrobial stewardshipQualitative researchIncremental cost-utility ratioPrimary healthcareBackground Despite their marginal benefit, about 60% of acute lower respiratory tract infections (ALRTIs) are currently treated with antibiotics in Catalonia. This study aims to evaluate the effectiveness and efficiency of a continuous disease-focused intervention (C-reactive protein [CRP]) and an illness-focused intervention (enhancement of communication skills to optimise doctor-patient consultations) on antibiotic prescribing in patients with ALRTIs in Catalan primary care centres. Methods/design A cluster randomised, factorial, controlled trial aimed at including 20 primary care centres (N = 2940 patients) with patients older than 18 years of age presenting for a first consultation with an ALRTI will be included in the study. Primary care centres will be identified on the basis of socioeconomic data and antibiotic consumption. Centres will be randomly assigned according to hierarchical clustering to any of four trial arms: usual care, CRP testing, enhanced communication skills backed up with patient leaflets, or combined interventions. A cost-effectiveness and cost-utility analysis will be performed from the societal and national healthcare system perspectives, and the time horizon of the analysis will be 1 year. Two qualitative studies (pre- and post-clinical trial) aimed to identify the expectations and concerns of patients with ALRTIs and the barriers and facilitators of each intervention arm will be run. Family doctors and nurses assigned to the interventions will participate in a 2-h training workshop before the inception of the trial and will receive a monthly intervention-tailored training module during the year of the trial period. Primary outcomes will be antibiotic use within the first 6 weeks, duration of moderate to severe cough, and the quality-adjusted life-years. Secondary outcomes will be duration of illness and severity of cough measured using a symptom diary, healthcare re-consultations, hospital admissions, and complications. Healthcare costs will be considered and expressed in 2021 euros (year foreseen to finalise the study) of the current year of the analysis. Univariate and multivariate sensitivity analyses will be carried out. Discussion The ISAAC-CAT project will contribute to evaluate the effectiveness and efficiency of different strategies for more appropriate antibiotic prescribing that are currently out of the scope of the actual clinical guidelines.The research is being funded by a grant from the Fundació La Marató de TV3 (reference no. 201820).BMC202020202019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/44669http://dx.doi.org/10.1186/s13063-019-3727-3reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésTrials. 2019 Dec 17;20:740This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/446692026-06-12T07:21:37Z
dc.title.none.fl_str_mv Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
title Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
spellingShingle Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
Ruiz, Rafa
Cost-effectiveness
Cost-utility
Effectiveness
Anti-bacterial agents
Prescribing
Acute cough
Respiratory tract infections
Antimicrobial stewardship
Qualitative research
Incremental cost-utility ratio
Primary healthcare
title_short Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
title_full Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
title_fullStr Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
title_full_unstemmed Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
title_sort Effectiveness and cost-effectiveness of Improving clinicians’ diagnostic and communication skills on antibiotic prescribing appropriateness in patients with acute cough in primary care in CATalonia (the ISAAC-CAT study): study protocol for a cluster randomised controlled trial
dc.creator.none.fl_str_mv Ruiz, Rafa
Moragas, Ana
Trapero-Bertran, Marta
Sisó, Antoni
Berenguera, Anna
Oliva, Glòria
Borràs Santos, Alícia
García Sangenís, Ana
Puig i Junoy, Jaume
Cots, Josep M.
Morros, Rosa
Mora, Toni
Lanau Roig, Anna
Monfà, Ramon
Troncoso, Amelia
Abellana, Rosa M.
Gálvez, Pau
Medina Perucha, Laura
Bjerrum, Lars
Amo, Isabel
Barragán, Nieves
Llor, Carl
author Ruiz, Rafa
author_facet Ruiz, Rafa
Moragas, Ana
Trapero-Bertran, Marta
Sisó, Antoni
Berenguera, Anna
Oliva, Glòria
Borràs Santos, Alícia
García Sangenís, Ana
Puig i Junoy, Jaume
Cots, Josep M.
Morros, Rosa
Mora, Toni
Lanau Roig, Anna
Monfà, Ramon
Troncoso, Amelia
Abellana, Rosa M.
Gálvez, Pau
Medina Perucha, Laura
Bjerrum, Lars
Amo, Isabel
Barragán, Nieves
Llor, Carl
author_role author
author2 Moragas, Ana
Trapero-Bertran, Marta
Sisó, Antoni
Berenguera, Anna
Oliva, Glòria
Borràs Santos, Alícia
García Sangenís, Ana
Puig i Junoy, Jaume
Cots, Josep M.
Morros, Rosa
Mora, Toni
Lanau Roig, Anna
Monfà, Ramon
Troncoso, Amelia
Abellana, Rosa M.
Gálvez, Pau
Medina Perucha, Laura
Bjerrum, Lars
Amo, Isabel
Barragán, Nieves
Llor, Carl
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Cost-effectiveness
Cost-utility
Effectiveness
Anti-bacterial agents
Prescribing
Acute cough
Respiratory tract infections
Antimicrobial stewardship
Qualitative research
Incremental cost-utility ratio
Primary healthcare
topic Cost-effectiveness
Cost-utility
Effectiveness
Anti-bacterial agents
Prescribing
Acute cough
Respiratory tract infections
Antimicrobial stewardship
Qualitative research
Incremental cost-utility ratio
Primary healthcare
description Background Despite their marginal benefit, about 60% of acute lower respiratory tract infections (ALRTIs) are currently treated with antibiotics in Catalonia. This study aims to evaluate the effectiveness and efficiency of a continuous disease-focused intervention (C-reactive protein [CRP]) and an illness-focused intervention (enhancement of communication skills to optimise doctor-patient consultations) on antibiotic prescribing in patients with ALRTIs in Catalan primary care centres. Methods/design A cluster randomised, factorial, controlled trial aimed at including 20 primary care centres (N = 2940 patients) with patients older than 18 years of age presenting for a first consultation with an ALRTI will be included in the study. Primary care centres will be identified on the basis of socioeconomic data and antibiotic consumption. Centres will be randomly assigned according to hierarchical clustering to any of four trial arms: usual care, CRP testing, enhanced communication skills backed up with patient leaflets, or combined interventions. A cost-effectiveness and cost-utility analysis will be performed from the societal and national healthcare system perspectives, and the time horizon of the analysis will be 1 year. Two qualitative studies (pre- and post-clinical trial) aimed to identify the expectations and concerns of patients with ALRTIs and the barriers and facilitators of each intervention arm will be run. Family doctors and nurses assigned to the interventions will participate in a 2-h training workshop before the inception of the trial and will receive a monthly intervention-tailored training module during the year of the trial period. Primary outcomes will be antibiotic use within the first 6 weeks, duration of moderate to severe cough, and the quality-adjusted life-years. Secondary outcomes will be duration of illness and severity of cough measured using a symptom diary, healthcare re-consultations, hospital admissions, and complications. Healthcare costs will be considered and expressed in 2021 euros (year foreseen to finalise the study) of the current year of the analysis. Univariate and multivariate sensitivity analyses will be carried out. Discussion The ISAAC-CAT project will contribute to evaluate the effectiveness and efficiency of different strategies for more appropriate antibiotic prescribing that are currently out of the scope of the actual clinical guidelines.
publishDate 2019
dc.date.none.fl_str_mv 2019
2020
2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/44669
http://dx.doi.org/10.1186/s13063-019-3727-3
url http://hdl.handle.net/10230/44669
http://dx.doi.org/10.1186/s13063-019-3727-3
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Trials. 2019 Dec 17;20:740
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BMC
publisher.none.fl_str_mv BMC
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405060716298240
score 15,812429